Monogram Sets Sept. 30 Shareholder Vote on $177M Zimmer Biomet Deal, $11M Fee If Terminated

Proxy Document Outlines $4.04 Cash Payout Plus Milestone-Based Payments Extending Through 2030.

 
• By Shubham Singh
  
The merger agreement was updated on Aug. 27 to revise the definition of “Permitted Transfer” in the Contingent Value Rights (CVR) agreement, following feedback from the Securities and Exchange Commission. Picture Courtesy: Shutterstock

More from Strategy

More from Business